Zobrazeno 1 - 10 of 27 pro vyhledávání: '"Carme, Talarn"'
1
Akademický článek
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Autor: José Luis Piñana, Rodrigo Martino, Irene García-García, Rocío Parody, María Dolores Morales, Gonzalo Benzo, Irene Gómez-Catalan, Rosa Coll, Ignacio De La Fuente, Alejandro Luna, Beatriz Merchán, Anabelle Chinea, Dunia de Miguel, Ana Serrano, Carmen Pérez, Carola Diaz, José Luis Lopez, Adolfo Jesús Saez, Rebeca Bailen, Teresa Zudaire, Diana Martínez, Manuel Jurado, María Calbacho, Lourdes Vázquez, Irene Garcia-Cadenas, Laura Fox, Ana I. Pimentel, Guiomar Bautista, Agustin Nieto, Pascual Fernandez, Juan Carlos Vallejo, Carlos Solano, Marta Valero, Ildefonso Espigado, Raquel Saldaña, Luisa Sisinni, Josep Maria Ribera, Maria Jose Jimenez, Maria Trabazo, Marta Gonzalez-Vicent, Noemí Fernández, Carme Talarn, Maria Carmen Montoya, Angel Cedillo, Anna Sureda, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
Publikováno v: Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-16 (2020)
Abstract Background Prognostic factors of poor outcome in patients with hematological malignancies and COVID-19 are poorly defined. Patients and methods This was a Spanish transplant group and cell therapy (GETH) multicenter retrospective observation
Externí odkaz: https://doaj.org/article/1193c5780a2148aaa7bcd60ef1b70ddd
Zobrazit plný text záznamu
2
Akademický článek
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis
Autor: Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, Ramon Guardia, Carme Talarn, Maite Encuentra, Eduard Fort, David López, Mireia Morgades, Eva Alonso, Sandra Ortega, Josep Sarrá, David Gallardo, Josep M. Ribera, Anna Sureda
Publikováno v: Oncology and Therapy, Vol 8, Iss 2, Pp 311-324 (2020)
Abstract Introduction Biosimilars of granulocyte colony-stimulating factors (G-CSF) have shown similar efficacy to originator filgrastim (Neupogen® [NEU]; Amgen Inc.) as prophylaxis in neutropenia and in the mobilization of stem cells in patients re
Externí odkaz: https://doaj.org/article/08f87789cf4846afad3186ad318c6185
Zobrazit plný text záznamu
5
A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection
Autor: Clara Maluquer, M Isabel González-Medina, S Ortega, Cristina Baca, G Bustamante, Rocío Parody, Eva Domingo-Domenech, E Cabezudo, Enric Carreras, V Clapés, Mar Sánchez-Salmerón, Concepción Boqué, A C Oliveira, S. Verdesoto, H Pomares, Montserrat Arnan, Beatriz Patiño, Marta Peña, Santiago Mercadal, Alberto Mussetti, I Sánchez-Ortega, L Escoda, Nadia García, Carme Talarn, C Fusté, Anna Sureda, Juliana Villa, Itziar Carro, Eva González-Barca
Publikováno v: Bone Marrow Transplantation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Traceability of patients who are candidates for Hematopoietic cell transplant (HCT) is crucial to ensure HCT program quality. Continuous knowledge of both a detailed registry from a HCT program and final exclusion causes can contribute to promoting a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e12f456c2d615b748157d46a8a09b518
https://pubmed.ncbi.nlm.nih.gov/34711917
Zobrazit plný text záznamu
6
P-032: Clinical characteristics and outcome of 30 patients with poems syndrome in Catalonia: impact of autologous stem cell transplantation in first line and at relapse
Autor: Anna Sureda, M Rovira, Alicia Senín, Lourdes Escoda, Eugenia Abella, M Fernandez-Aguilera, Victoria Clapés, J Marti-Tutusaus, M. Gironella, Carlos Castillo-Girón, J. Bladé, MT Cibeira, Laura Rosiñol, Carme Talarn, A. Oriol, C. Fernández de Larrea
Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S55-S56
Background POEMS syndrome is a rare paraneoplastic disease caused by an underlying plasma cell disorder. The aim of this study is to describe clinical and biological features as well as outcomes in a series of patients in a real-world clinical settin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2aaa5f312cefbb5d8bdd98926f4d39db
https://doi.org/10.1016/s2152-2650(21)02166-2
Zobrazit plný text záznamu
9
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Autor: Carmen Eva Perez, Maria Trabazo, Diana Martínez, Irene Garcia-Garcia, Carola Diaz, Rocío Parody, Rosa Coll, José Luis Piñana, Rebeca Bailén, Ignacio De La Fuente, Marta Valero, María-José Jiménez, Irene García-Cadenas, Teresa Zudaire, I Espigado, Agustin Nieto, Ana Serrano, Angel Cedillo, Noemí Fernández, Guiomar Bautista, Adolfo Saez, María Dolores Morales, Luisa Sisinni, Beatriz Merchán, Lourdes Vázquez, Anna Sureda, Laura Fox, Josep-Maria Ribera, Rodrigo Martino, Alejandro Luna, Ana I. Pimentel, Juan Carlos Vallejo, Gonzalo Benzo, Jose Lopez, Carme Talarn, Raquel Saldaña, María Calbacho, Anabelle Chinea, Dunia de Miguel, Maria Carmen Montoya, Manuel Jurado, Irene Gómez-Catalan, Carlos Solano, Marta González-Vicent, Pascual Fernández
Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-16 (2020)
Scientia
Experimental Hematology & Oncology
Background Prognostic factors of poor outcome in patients with hematological malignancies and COVID-19 are poorly defined. Patients and methods This was a Spanish transplant group and cell therapy (GETH) multicenter retrospective observational study,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed6d8fd73d4e915ad1a968cc4a2a7f4
http://hdl.handle.net/2445/174432
Zobrazit plný text záznamu
10
Bone marrowVEGFCexpression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival
Autor: Llorenç Font, Maria Luz Amigo, Carme Pedro, Ana Garrido, David Gallardo, Antoni Garcia-Guiñon, Maria Paz Queipo De Llano, Josep-Maria Ribera, Josep M Marti-Tutusaus, Salut Brunet, Lourdes Escoda, Olga Salamero, Marisa Calabuig, Montserrat Arnan, Vicent Guillem, Carme Talarn, Jordi Sierra, Montserrat Hoyos, Jordi Esteve, Josep F. Nomdedeu, Joan Bargay, Mar Tormo, Blanca Navarro, Marina Díaz-Beyá, Antonia Sampol
Publikováno v: LEUKEMIA & LYMPHOMA
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Vascular endothelial growth factor C (VEGFC) stimulates leukemia cell proliferation and survival, and promotes angiogenesis. We studied VEGFC expression in bone marrow samples from 353 adult acute myeloid leukemia (AML) patients and its relationship
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af314581e9ca7b58e24ac0d36841059
https://doi.org/10.1080/10428194.2017.1422858
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje